We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Diagnostic Accuracy of Protein/Creatinine Ratio Influenced by Urine Concentration

By LabMedica International staff writers
Posted on 29 Sep 2015
The diagnosis and management of proteinuric renal diseases and the staging of chronic kidney disease (CKD) require accurate identification and quantitation of proteinuria.

The usage of urine protein/creatinine ratio to estimate daily urine protein excretion is prevalent, but relatively little attention has been paid to the influence of urine concentration and its impact on test accuracy.

Scientists at the Taipei Veterans General Hospital (Taiwan) and their colleagues collected 540 urine samples with complete data of 24 hour urine protein concentration, creatinine concentration, total volume, and most importantly, a concomitant urinalysis of the same urine sample. More...
After the total volume of the 24 hour urine sample had been measured and the storage container had been gently shaken for 10 seconds to mix the urine, two 10 mL specimens were sent for urinalysis and urine protein creatinine concentration measurement, respectively.

The urine protein and creatinine concentration of 24 hour and spot urine were both determined by the Hitachi 7180 Autoanalyzer (Hitachi; Tokyo, Japan). The specific gravity of the urinalysis was analyzed by using the Clinitek Atlas Automated Urine Chemistry Analyzer (Siemens Healthcare Diagnostics; Erlangen, Germany). In order to a compare distribution patterns of urine creatinine concentration between 24 hour and spot urine samples, a concurrent database of single voided urine samples collected during June 2010 to May 2014 were examined. Spot urine samples were collected at any time point of the day. There were 31,551 urine protein/creatinine ratio (UPCR) spot samples with a concomitant urinalysis examination.

The investigators found that found that for dilute urine samples with specific gravity equal to or less than 1.005, a sample with urine creatinine equal to or less than 38.8 mg/dL was more likely to overestimate actual daily urine protein excretion by using UPCR. For urine samples with specific gravity equal to or greater than 1.015, equal to or greater than 1.020, and equal to or greater than 1.025, those with urine creatinine concentration equal to or greater than 63.6 mg/dL, equal to or greater than 62.1 mg/dL, equal to or greater than 61.5 mg/dL, respectively, were more likely to lead to an underestimation.

The authors concluded that the UPCR in samples with low or high specific gravity is more likely to overestimate or underestimate actual daily urine protein amount, respectively, especially in a dilute urine sample with its creatinine below 38.8 mg/dL or a concentrated sample with its creatinine above 61.5 mg/dL. In particular, UPCR results should be interpreted with caution in cases that involve dilute urine samples because its overestimation may lead to an erroneous diagnosis of proteinuric renal disease or an incorrect staging of chronic kidney disease. The study was published on September 9, 2015, in the journal PLOS ONE.

Related Links:

Taipei Veterans General Hospital
Hitachi
Siemens Healthcare Diagnostics 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
All-in-One Molecular System
AIO M160
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.